Randomized, placebo-controlled study of Lamifiban with thrombolytic therapy for the treatment of acute myocardial infarction: Rationale and design for the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) study

✍ Scribed by David J. Moliterno; Robert A. Harrington; Robert M. Califf; Hans J. Rapold; Eric J. Topol

• Publisher: Springer US
• Year: 1995
• Tongue: English
• Weight: 583 KB
• Volume: 2
• Category: Article
• ISSN: 0929-5305
• DOI: 10.1007/bf01062706